These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 19364980
1. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R. Circulation; 2009 Apr 28; 119(16):2209-16. PubMed ID: 19364980 [Abstract] [Full Text] [Related]
2. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content. Abdul-Hussien H, Hanemaaijer R, Verheijen JH, van Bockel JH, Geelkerken RH, Lindeman JH. J Vasc Surg; 2009 Mar 28; 49(3):741-9. PubMed ID: 19268776 [Abstract] [Full Text] [Related]
3. The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. Abdul-Hussien H, Hanemaaijer R, Kleemann R, Verhaaren BF, van Bockel JH, Lindeman JH. J Vasc Surg; 2010 Jun 28; 51(6):1479-87. PubMed ID: 20488324 [Abstract] [Full Text] [Related]
4. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm. Lindeman JH, Abdul-Hussien H, Schaapherder AF, Van Bockel JH, Von der Thüsen JH, Roelen DL, Kleemann R. Clin Sci (Lond); 2008 Jun 28; 114(11):687-97. PubMed ID: 18078385 [Abstract] [Full Text] [Related]
8. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, Saikku P, Juvonen T. J Vasc Surg; 2001 Oct 28; 34(4):606-10. PubMed ID: 11668312 [Abstract] [Full Text] [Related]
9. Doxycycline treatment in a model of early abdominal aortic aneurysm. Kaito K, Urayama H, Watanabe G. Surg Today; 2003 Oct 28; 33(6):426-33. PubMed ID: 12768368 [Abstract] [Full Text] [Related]
10. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Huffman MD, Curci JA, Moore G, Kerns DB, Starcher BC, Thompson RW. Surgery; 2000 Sep 28; 128(3):429-38. PubMed ID: 10965315 [Abstract] [Full Text] [Related]
11. The effect of acute normovolaemic haemodilution on the inflammatory response and clinical outcome in abdominal aortic aneurysm repair--results of a pilot trial. Wolowczyk L, Nevin M, Day A, Smith FC, Baird RN, Lamont PM. Eur J Vasc Endovasc Surg; 2005 Jul 28; 30(1):12-9. PubMed ID: 15933977 [Abstract] [Full Text] [Related]
12. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Thompson RW, Baxter BT. Ann N Y Acad Sci; 1999 Jun 30; 878():159-78. PubMed ID: 10415728 [Abstract] [Full Text] [Related]
13. Elastin stabilization for treatment of abdominal aortic aneurysms. Isenburg JC, Simionescu DT, Starcher BC, Vyavahare NR. Circulation; 2007 Apr 03; 115(13):1729-37. PubMed ID: 17372168 [Abstract] [Full Text] [Related]
14. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Chung AW, Yang HH, Radomski MW, van Breemen C. Circ Res; 2008 Apr 25; 102(8):e73-85. PubMed ID: 18388324 [Abstract] [Full Text] [Related]
15. Rapamycin suppresses experimental aortic aneurysm growth. Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR. J Vasc Surg; 2004 Aug 25; 40(2):334-8. PubMed ID: 15297830 [Abstract] [Full Text] [Related]
16. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Kajimoto K, Miyauchi K, Kasai T, Shimada K, Kojima Y, Shimada A, Niinami H, Amano A, Daida H. Atherosclerosis; 2009 Oct 25; 206(2):505-11. PubMed ID: 19406402 [Abstract] [Full Text] [Related]
17. Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Caligiuri G, Rossignol P, Julia P, Groyer E, Mouradian D, Urbain D, Misra N, Ollivier V, Sapoval M, Boutouyrie P, Kaveri SV, Nicoletti A, Lafont A. Arterioscler Thromb Vasc Biol; 2006 Mar 25; 26(3):618-23. PubMed ID: 16357310 [Abstract] [Full Text] [Related]
19. Fucoidan interferes with Porphyromonas gingivalis-induced aneurysm enlargement by decreasing neutrophil activation. Alsac JM, Delbosc S, Rouer M, Journé C, Louedec L, Meilhac O, Michel JB. J Vasc Surg; 2013 Mar 25; 57(3):796-805. PubMed ID: 23141684 [Abstract] [Full Text] [Related]
20. A global assessment of the inflammatory response elicited upon open abdominal aortic aneurysm repair. Vasdekis SN, Argentou M, Kakisis JD, Bossios A, Gourgiotis D, Karanikolas M, Karatzas G. Vasc Endovascular Surg; 2008 Mar 25; 42(1):47-53. PubMed ID: 18238867 [Abstract] [Full Text] [Related] Page: [Next] [New Search]